See the Complete Picture.

Browser Extension

Monday, May 19, 2025

US Edition

Subscribe Login

Natural Disasters

Democratic Party

Artificial Intelligence

Israel-Hamas Conflict

Cannes Film Festival

fiercepharma.com image

News from fiercepharma.com

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Cricket Social Media Natural Disasters WWE Soccer

Trending in U.S.Israel-Hamas Conflict Baseball US Politics Donald Trump Joe Biden

Trending in U.K.Israel-Hamas Conflict Premier League Soccer Manchester City Arsenal FC

Trending Topics

Cricket Social Media Natural Disasters WWE Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from fiercepharma.com

Stay current with all the latest and breaking news from fiercepharma.com. Compare headlines and media bias behind news outlets on stories breaking today.

Overall, we’ve indexed 6 stories from fiercepharma.com over the past 3 months.

We’ve assigned a media bias rating of Center to fiercepharma.com. You can read more about our methodology here.

fiercepharma.com’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Stay current with all the latest and breaking news from fiercepharma.com. Compare headlines and media bias behind news outlets on stories breaking today. Overall, we’ve indexed 6 stories from fiercepharma.com over the past 3 months.

We’ve assigned a media bias rating of Center to fiercepharma.com. You can read more about our methodology here. fiercepharma.com’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about fiercepharma.com

Where is fiercepharma.com located?fiercepharma.com's Website

Media Bias Ratings

Average Bias Rating:

Center

Center

byMedia Bias/Fact Check

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top fiercepharma.com News

European pharma companies issue demands to stay in EU

European pharma companies issue demands to stay in EU

67% Center coverage: 3 sources

Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to maintain operations in the EU despite threatened US tariffs on imports, French business newspaper Les Echos has reported.See the Story

Pharma warns EU of "exodus to US" without reform

Ursula Von Der Leyen

Pharma warns EU of "exodus to US" without reform

45% Center coverage: 9 sources

At the same time that Donald Trump was saying that a "major tariff" on pharmaceuticals is coming to force more manufacturers to relocate to the US, pharma leaders told the EU that – without reforms – the bloc could lose out on capital investment programmes and R&D spending.See the Story

European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval

European committee says Lilly Alzheimer’s drug shouldn’t get marketing approval

50% Center coverage: 18 sources

You've scrolled to the bottom of the feed, there are no more stories.

Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

Coverage: 8 sources

Switzerland Economy · Switzerland See the Story

Pfizer Considers Relocating Overseas Manufacturing to US Facilities

Pfizer Considers Relocating Overseas Manufacturing to US Facilities

Pfizer Considers Relocating Overseas Manufacturing to US Facilities

56% Center coverage: 9 sources

Tariffs · United States See the Story